CDIOCardio Diagnostics HoldingsCDIO info
$0.28info3.36%24h
Global rank34199
Market cap$5.75M
Change 7d-7.25%
YTD Performance-88.84%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Business data

    Cardio Diagnostics Holdings (CDIO) Stock Overview

    Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.

    CDIO Stock Information

    Symbol
    CDIO
    Address
    400 North Abderdeen StreetChicago, IL 60642United States
    Founded
    -
    Trading hours
    -
    Website
    https://cardiodiagnosticsinc.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    302 281 2147

    Cardio Diagnostics Holdings (CDIO) Price Chart

    -
    Value:-

    Cardio Diagnostics Holdings Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.2801
    N/A
    Market Cap
    $5.75M
    N/A
    Shares Outstanding
    20.52M
    N/A
    Employees
    7.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org